Search results for "Epidemiology"

showing 10 items of 4214 documents

Refined Analysis of a Cross-Sectional Doping Survey Among Recreational Triathletes: Support for the Nutritional Supplement Gateway Hypothesis

2020

Introduction: The current literature provides no consensus that nutritional supplements (NS) may provide a gateway to doping. In particular, studies in recreational athletes are lacking. Within a previous cross-sectional empirical study, our group provided first evidence that the use of NS may provide a gateway for the use of doping substances in recreational triathletes. For the present paper, we refine the analysis of the triathletes’ survey in order to provide evidence for a NS gateway hypothesis in recreational athletes. Methods: A self-report, paper-and-pencil questionnaire was distributed to a sample of 2,997 competitive ironman and half-ironman (n = 1,076; 36.1%) triathletes. The ran…

biologyAthletesRandomized Response Techniquelcsh:BF1-99005 social sciencesDirect questioningnutritional supplementsdopingGateway (computer program)biology.organism_classificationtriathletes050105 experimental psychology03 medical and health scienceslcsh:Psychology0302 clinical medicineEnvironmental healthPerspectivegatewayPsychologyepidemiology0501 psychology and cognitive sciencesPsychologyRecreation030217 neurology & neurosurgeryGeneral PsychologyFrontiers in Psychology
researchProduct

P3‐271: Presenilin‐1 (PS1) and amyloid precursor protein (APP) mutations present in mouse models of Alzheimer's disease in their response to γ‐secret…

2009

biologyEpidemiologyChemistryHealth PolicyBACE1-ASP3 peptideDiseasePresenilinBiochemistry of Alzheimer's diseasePsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceAlpha secretasebiology.proteinCancer researchAmyloid precursor proteinNeurology (clinical)Geriatrics and GerontologyAmyloid precursor protein secretaseAlzheimer's & Dementia
researchProduct

P4‐256: POSITIVE FEEDBACK LOOP OF APC/C‐CDH1‐MEDIATED EXCITOTOXICITY IN ALZHEIMER'S DISEASE

2014

biologyEpidemiologybusiness.industryHealth PolicyExcitotoxicityDiseasemedicine.disease_causeCDH1Psychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental Neurosciencebiology.proteinmedicineNeurology (clinical)Geriatrics and GerontologybusinessNeurosciencePositive feedbackAlzheimer's & Dementia
researchProduct

Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany

2008

In recent years, Clostridium difficile infection (CDI) has emerged as an increasing problem, both in in- and outpatients. In a rural region of southern Germany, the annual number of C. difficile toxin (Tcd)-positive patients has increased from 95 to 796 in the period from 2000 to 2007. Simultaneously, the proportion of positive tests among all Tcd examinations has risen from 7.0% to 12.8%, indicating that the higher number of affected patients was not solely due to an increase in the number of assays. Elevated numbers of CDI have recently been associated with outbreaks of the ribotype 027 strain, particularly in North America. This strain has also been isolated in Europe, including in Germa…

biologyEpidemiologybusiness.industryPublic Health Environmental and Occupational HealthOutbreakErythromycinClostridium difficilebiology.organism_classificationMicrobiologyCiprofloxacinDiarrheaRibotypingAntibiotic resistanceVirologymedicineClostridiaceaemedicine.symptombusinessmedicine.drugEurosurveillance
researchProduct

Chapter 2 Fasciola, Lymnaeids and Human Fascioliasis, with a Global Overview on Disease Transmission, Epidemiology, Evolutionary Genetics, Molecular …

2009

Abstract Fascioliasis, caused by liver fluke species of the genus Fasciola, has always been well recognized because of its high veterinary impact but it has been among the most neglected diseases for decades with regard to human infection. However, the increasing importance of human fascioliasis worldwide has re‐launched interest in fascioliasis. From the 1990s, many new concepts have been developed regarding human fascioliasis and these have furnished a new baseline for the human disease that is very different to a simple extrapolation from fascioliasis in livestock. Studies have shown that human fascioliasis presents marked heterogeneity, including different epidemiological situations and…

biologyFasciolaMolecular epidemiologyHuman evolutionary geneticsHepaticaFasciola giganticaBiological dispersalZoologybiology.organism_classificationGenetic isolateFasciolidae
researchProduct

368 Growth of Infant Fed Starter Formula Containing Prebiotics or Symbiotic

2010

Objective: To assess growth of infants fed starter formula supplemented with either prebiotics or symbiotic. In addition, gut microbiota was studied. Methods: Healthy, full term newborns (n= 240) were enrolled before the 14th day of their life and randomly assigned between 3 exclusively formula fed groups: starter IF, starter IF + prebiotics (CMOS+GOS), starter IF + prebiotics (CMOS+GOS) and probiotics (BL999 + LPR). Growth was assessed by body weight gain during 4 months. Gut microbiota profile was examined by measuring fecal counts in Bifidobacteria, Lactobacilli, Enterobacteria, Clostridium at 2 months of age. Incidence of morbidity was appraised. Results: Non inferiority in growth was e…

biologyPrebioticmedicine.medical_treatmentIncidence (epidemiology)Gut florabiology.organism_classificationConfidence intervalAnimal scienceClostridiumStarterPediatrics Perinatology and Child HealthmedicineFecesFull TermPediatric Research
researchProduct

AB1358 Infectious antibodies repertoire in rheumatoid arthritis

2018

Background The incidence of infectious diseases in the RA ADAPTHERA study by ELISA antibody screening and the differences in infectious distribution in active or low active disease patients was explored. Methods Sera from 88 naive RA patients out of the ADAPTHERA study cohort, disease duration Results 82% RA patients were found to be positive for HSV1 +2 IgG (2% IgM positive), 8% for Adenovirus (IgA), 77% (IgG), and 1% (IgM). 99% for EBV-IgG (no IgM positive). 53% (IgG), and 26% (IgM) for CMV. 38% for HP-IgG and 15% for IgA and 79% for P-B19-IgG (3% IgM). 6% for Borrelia-IgM and 14% for IgG. A slightly increase was found for EBV sera positivity (99% IgG), compared to the normal population. …

biologybusiness.industryIncidence (epidemiology)medicine.diseasePathophysiologyRheumatoid arthritisImmunologyActive diseaseCohortmedicinebiology.proteinLimited evidenceAntibodybusinessAntibody screeningValidation of outcome measures and biomarkers
researchProduct

Neuropsychological underpinnings of the dynamics of bipolar disorder

2015

Although we have gained enormous insights into neurobiological and psychological underpinnings of bipolar disorder (BD) symptoms, our knowledge concerning pathogenic mechanisms initiating recurrent affective episodes is still fragmentary. Previous research has highlighted the role of significant life events and social rhythm in recurrent episodes of mania and depression. However, most studies share the drawback of retrospective self-report data, which are prone to recall biases and limited introspective abilities. Therefore, more objective data, such as neuropsychological and neurobiological measures are needed to further unravel the pathogenic mechanisms of the dynamics of bipolar disorder…

bipolar disorderBiological markersRecallEpidemiologyPublic Health Environmental and Occupational HealthNeuropsychologyBiological markers; bipolar disorder; brain imaging techniques; prospective studyCognitionEpidemiology for Behavioural Neurosciencesmedicine.diseaseDevelopmental psychologybrain imaging techniquesPsychiatry and Mental healthNeuroimagingMultiple timemedicineBipolar disordermedicine.symptomPsychologyManiaDepression (differential diagnoses)Clinical psychologyprospective study
researchProduct

Data from: Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy

2019

Background. For many years, long-acting intramuscular (LAI) antipsychotics have been prescribed predominantly to chronic and severe patients, as a last resort when other treatments failed. Recently, a broader and earlier use of LAIs, particularly second-generation LAIs, has been emphasized. To date, few studies attempted to frame how this change in prescribing took place in real-world practice. Therefore, this study aimed to describe the clinical features of patients prescribed with LAIs, and to explore possible prescribing differences between first- and second-generations LAIs under ordinary clinical practice in Italy. Methods. The STAR Network "Depot" Study is an observational, longitudin…

bipolar disorderpharmacoepidemiologyvirusesLife Sciencesvirus diseaseslong-acting injectable antipsychoticsadherence to antipsychoticsDecember 2015-May 2017medicine and health careschizophreniaantipsychoticsimmune system diseasesMedicineoff-label prescriptionsdepot antipsychotics
researchProduct

Oral Squamous Cell Carcinoma on Gingiva, Edentulous Ridge, and Retromolar Pad: A Case Series

2021

(1) Background: Gingival cancer has a significant incidence and is often diagnosed at advanced stages. The aim of this paper is to highlight its clinical aspects on the basis of a case series analysis in order to promote awareness and improve the diagnosis process. (2) Methods: Oral cancers diagnosed and treated at three Italian University Hospitals over ten years were retrospectively investigated. Cancer location on the gingiva, edentulous ridge, and retromolar pad was addressed. Data regarding clinical features, stage at the diagnosis, and time from presenting symptoms to first medical consultation were retrieved. (3) Results: Thirty-three cancers located on the gingiva, edentulous ridge,…

business.industrydiagnosisIncidence (epidemiology)MandibleCancerDentistryClinical appearanceMedical evaluationRK1-715030206 dentistryoral cancermedicine.diseaseAsymptomaticgingiva03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisDentistrymedicineBasal cellclinical appearanceStage (cooking)medicine.symptombusiness
researchProduct